smell loss

FDA Clears Application for Phase 2 Clinical Trial of CYR-064 to Treat Post-Viral Smell Loss
Drugs.com
Thu, 01/19/23 - 09:48 am
Cyrano Therapeutics
smell loss
hyposmia
CYR-064
clinical trials
FDA